Skip to menu Skip to content Skip to footer

2022

Book Chapter

Dialysis dose and adequacy for hemodialysis

Smyth, Brendan, Hawley, Carmel M. and Jardine, Meg (2022). Dialysis dose and adequacy for hemodialysis. Evidence-based nephrology. (pp. 20-33) edited by Jonathan C. Craig, Donald A. Molony and Giovanni F. M. Strippoli. Hoboken, NJ USA: John Wiley & Sons. doi: 10.1002/9781119105954.ch41

Dialysis dose and adequacy for hemodialysis

2016

Book Chapter

Complications of peritoneal dialysis

Kennard, Alice, Johnson, David W. and Hawley, Carmel M. (2016). Complications of peritoneal dialysis. Core concepts in dialysis and continuous therapies. (pp. 121-133) edited by Colm C. Magee, J. Kevin Tucker and Ajay K. Singh. Boston, MA, United States: Springer. doi: 10.1007/978-1-4899-7657-4_10

Complications of peritoneal dialysis

2013

Book Chapter

Planning and maintaining functional vascular access in a haemodialysis population

Polkinghorne, K. R., Fahim, M. A., Gunatillake, N. and Hawley, C. M. (2013). Planning and maintaining functional vascular access in a haemodialysis population. Renal failure: prevention, causes and treatment. (pp. 89-115) edited by Colin Andrew Hutchison. New York, NY United States: Nova Science Publishers, Inc..

Planning and maintaining functional vascular access in a haemodialysis population

2013

Book Chapter

Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations

Fahim, M. A. and Hawley, C. M. (2013). Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations. Renal failure: prevention, causes and treatment. (pp. 17-35) edited by Colin Andrew Hutchison. New York, United States: Nova Science Publishers.

Cardiovascular disease in the chronic kidney disease population - burden, pathophysiology and end-organ manifestations

2013

Book Chapter

An overview of erythropoietin therapy

Zirapury, Tasnim, van Eps, Carolyn, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2013). An overview of erythropoietin therapy. Erythropoietin: human production, potential uses and adverse effects. (pp. 31-53) New York, NY, United States: Nova Science Publishers.

An overview of erythropoietin therapy

2012

Book Chapter

How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?

Badve, Sunil V., Hawley, Carmel M. and Johnson, David W. (2012). How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?. Issues in Dialysis. (pp. xx-xx) edited by Stephen Z. Fadem. New York, NY, U.S.A.: Nova Science Publishers.

How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?